#ThroughTheGenes is an informative podcast highlighting the risks, benefits, and limitations of gene- and cell-based therapies as curative options for sickle cell disease. The show is hosted by sickle sisters Wunmi Bakare and Dima Hendricks. It takes you behind the lived experience of patients who participated in the curative process, revealing their highs, lows, and everything in between.
This collaborative effort aims to help patients and their support networks navigate emerging developments in gene therapies for sickle cell disease.
All content for #ThroughTheGenes is the property of #ThroughTheGenes and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
#ThroughTheGenes is an informative podcast highlighting the risks, benefits, and limitations of gene- and cell-based therapies as curative options for sickle cell disease. The show is hosted by sickle sisters Wunmi Bakare and Dima Hendricks. It takes you behind the lived experience of patients who participated in the curative process, revealing their highs, lows, and everything in between.
This collaborative effort aims to help patients and their support networks navigate emerging developments in gene therapies for sickle cell disease.
<p>In this episode of <a href="https://www.youtube.com/hashtag/throughthegenes" rel="ugc noopener noreferrer" target="_blank">#ThroughTheGenes</a>, we’re excited to welcome back Dr. Staci Martin as she puts Acceptance and Commitment Therapy (ACT) into practice. Dr. Martin provides an in-depth exploration of mental health challenges specific to individuals with sickle cell disease, especially those undergoing curative therapy.</p>
#ThroughTheGenes
#ThroughTheGenes is an informative podcast highlighting the risks, benefits, and limitations of gene- and cell-based therapies as curative options for sickle cell disease. The show is hosted by sickle sisters Wunmi Bakare and Dima Hendricks. It takes you behind the lived experience of patients who participated in the curative process, revealing their highs, lows, and everything in between.
This collaborative effort aims to help patients and their support networks navigate emerging developments in gene therapies for sickle cell disease.
